D-Index & Metrics Best Publications
Research.com 2022 Best Scientist Award Badge
Medicine
Germany
2022

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 154 Citations 94,959 717 World Ranking 358 National Ranking 9
Best Scientists D-index 159 Citations 108,839 750 World Ranking 873 National Ranking 31

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Scientist Award

2022 - Research.com Medicine in Germany Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

The scientist’s investigation covers issues in Cancer research, Pathology, Glioma, Astrocytoma and IDH1. His research integrates issues of Immunohistochemistry, Mutation, ATRX, Loss of heterozygosity and Tumor suppressor gene in his study of Cancer research. Andreas von Deimling combines subjects such as DNA methylation and Gene expression profiling with his study of Pathology.

His work deals with themes such as Histone, Methylation, Bioinformatics and Histopathology, which intersect with DNA methylation. His Glioma study integrates concerns from other disciplines, such as Internal medicine, CD8 and Oncology. His Oligodendroglioma research focuses on Molecular biology and how it relates to Mutant.

His most cited work include:

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. (6125 citations)
  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (1542 citations)
  • Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. (1510 citations)

What are the main themes of his work throughout his whole career to date?

Cancer research, Pathology, Glioma, DNA methylation and Internal medicine are his primary areas of study. His study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Tumor suppressor gene, Gene, Carcinogenesis and Loss of heterozygosity. His Pathology study incorporates themes from Astrocytoma and Oligodendroglioma.

His work in Glioma addresses subjects such as IDH1, which are connected to disciplines such as Isocitrate dehydrogenase and Molecular biology. His DNA methylation research incorporates themes from Methylation and Epigenetics. His research in Internal medicine focuses on subjects like Oncology, which are connected to Temozolomide, Bioinformatics and Cancer.

He most often published in these fields:

  • Cancer research (55.09%)
  • Pathology (49.18%)
  • Glioma (29.57%)

What were the highlights of his more recent work (between 2019-2021)?

  • Cancer research (55.09%)
  • DNA methylation (29.46%)
  • Pathology (49.18%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, DNA methylation, Pathology, Internal medicine and Glioma. His Cancer research study combines topics in areas such as Mutation, Epigenetics, Immune system and GLI2. His research in DNA methylation intersects with topics in Astrocytoma, Methylation, CDKN2A and Copy-number variation.

His work on Pathology is being expanded to include thematically relevant topics such as Mutation. The Internal medicine study combines topics in areas such as Glioblastoma, Oncology and MEDLINE. The study incorporates disciplines such as Cytotoxic T cell, Isocitrate dehydrogenase, Chemotherapy and Wild type in addition to Glioma.

Between 2019 and 2021, his most popular works were:

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)
  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)
  • cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. (83 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

His scientific interests lie mostly in DNA methylation, Pathology, Cancer research, Internal medicine and MEDLINE. His DNA methylation research incorporates elements of Carcinogenesis, Astrocytoma, Pineoblastoma and Retinoblastoma. He has included themes like Fusion gene and Methylation in his Pathology study.

His studies in Cancer research integrate themes in fields like Immune checkpoint, Papillary tumor and Immune system. The concepts of his Internal medicine study are interwoven with issues in Oncology and Profiling. His study in the field of Diffuse Glioma is also linked to topics like Kappa.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

David N. Louis;Arie Perry;Guido Reifenberger;Andreas von Deimling.
Acta Neuropathologica (2016)

8837 Citations

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

Daniel J. Brat;Roel G.W. Verhaak;Kenneth D. Aldape;W. K.Alfred Yung.
The New England Journal of Medicine (2015)

1955 Citations

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones.
Nature (2012)

1923 Citations

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang.
Cancer Cell (2012)

1438 Citations

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Christiane A. Opitz;Ulrike M. Litzenburger;Ulrike M. Litzenburger;Felix Sahm;Martina Ott.
Nature (2011)

1305 Citations

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper.
Acta Neuropathologica (2009)

1089 Citations

Analysis of the IDH1 codon 132 mutation in brain tumors

Jörg Balss;Jochen Meyer;Wolf Mueller;Andrey Korshunov;Andrey Korshunov.
Acta Neuropathologica (2008)

1088 Citations

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

Catherine L. Nutt;D. R. Mani;Rebecca A. Betensky;Pablo Tamayo.
Cancer Research (2003)

1084 Citations

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.

Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik.
Acta Neuropathologica (2011)

1084 Citations

Long-term survival with glioblastoma multiforme

Dietmar Krex;Barbara Klink;Christian Hartmann;Andreas Von Deimling.
Brain (2007)

891 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Andreas von Deimling

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 377

Michael Weller

Michael Weller

University of Zurich

Publications: 261

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 239

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 212

Arie Perry

Arie Perry

University of California, San Francisco

Publications: 179

Marcel Kool

Marcel Kool

German Cancer Research Center

Publications: 157

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 145

Torsten Pietsch

Torsten Pietsch

University of Bonn

Publications: 143

David N. Louis

David N. Louis

Harvard University

Publications: 142

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 141

Keith L. Ligon

Keith L. Ligon

Harvard University

Publications: 137

Guido Reifenberger

Guido Reifenberger

Heinrich Heine University Düsseldorf

Publications: 132

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 128

Pieter Wesseling

Pieter Wesseling

University of Amsterdam

Publications: 126

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 119

Cynthia Hawkins

Cynthia Hawkins

University of Toronto

Publications: 116

Trending Scientists

Thomas Schwentick

Thomas Schwentick

TU Dortmund University

Winston H. Hsu

Winston H. Hsu

National Taiwan University

Aldo Geuna

Aldo Geuna

University of Turin

Hans-Joachim Voth

Hans-Joachim Voth

University of Zurich

Yongcheol Shin

Yongcheol Shin

University of York

Eric Renault

Eric Renault

University of Warwick

J. Ilja Siepmann

J. Ilja Siepmann

University of Minnesota

Claudio E. Sunkel

Claudio E. Sunkel

University of Porto

Luca Luiselli

Luca Luiselli

Institute for Development Ecology Conservation and Cooperation

Jon Eischeid

Jon Eischeid

University of Colorado Boulder

Jiang-Ning Zhou

Jiang-Ning Zhou

University of Science and Technology of China

Anouk Scheres

Anouk Scheres

Radboud University Nijmegen

Christos Pitsavos

Christos Pitsavos

National and Kapodistrian University of Athens

Peter Roy-Byrne

Peter Roy-Byrne

University of Washington

François Cambien

François Cambien

University of Bordeaux

Something went wrong. Please try again later.